ANDA 63117, held by Hikma. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 63117 (Tobramycin Sulfate), held by Hikma, was first approved by FDA on Apr 26, 1991, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 26, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin SulfateEQ 40MG BASE/ML · injectable;injection | Tobramycin Sulfate | Rx |
| Jan 17, 2023 | Supplement 9Labeling · Standard review | Approved | None posted |
| Feb 26, 2002 | Supplement 8Labeling | Approved | None posted |
| Jul 23, 2001 | Supplement 7Labeling | Approved | None posted |
| Aug 30, 2000 | Supplement 6Labeling | Approved | None posted |
| Apr 25, 2000 | Supplement 5Labeling | Approved | None posted |
| Sep 13, 1996 | Supplement 4Manufacturing | Approved | None posted |
| Aug 17, 1994 | Supplement 2Manufacturing | Approved | None posted |
| Jul 28, 1994 | Supplement 3Labeling | Approved | None posted |
| Apr 27, 1993 | Supplement 1Labeling | Approved | None posted |
| Apr 26, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters